increase in multidetector computed tomography (MDCT) use during the last decade.
Recent studies have confirmed that expanding hematoma occurs in approximately 70% of patients undergoing CT scan within the first 3 hours of stroke, suggesting that certain findings on MDCT angiography are likely predictors of growth hemorrhage 3, 4 . The most important predictor of mortality and neurological disability is the initial volume of the ICH; however, hematoma expansion leads to a conservative prognosis. The presence and characteristics of an active extravasation of contrast within the ICH (spot sign) was initially detected on angiography as a predictor of hemorrhage expansion 5 . This imaging sign has also been reproduced on MDCT angiography as a robust predictor of expansion and as an indicator of worse prognosis and mortality 3, 4 . MDCT angiography has been proven to be a rapid and reproducible alternative to catheter angiography that reduces the risks to the enrolled patients and offers significant benefits to the decision-making process [6] [7] [8] [9] . A higher incidence of hemorrhagic stroke has been repor ted in the Latin American population [10] [11] [12] [13] . Inherited ethnic factors attributed to miscegenation have been implicated in addition to several environmental characteristics, such as diet, often pre-existing long-term untreated arterial hypertension, and delayed access of Brazilians to emergency rooms, all of which presumably contribute to the worsening health conditions in our population. These features might influence the clinical and/or imaging patterns.
To the best of our knowledge, this is the first MDCT study of primary ICH to examine a large sample of Latin American patients. It remains necessary to reproduce the applicability of MDCT angiography and to evaluate the effects of he mostatic drugs on this population.
Our primary aims are to study the spot sign characteristic that can be observed on MDCT scans, and to assess the relationship of this finding with mortality and expansion in a cohort of patients with primary ICH. The relevance of the current study derives from the potential reproducibility of this procedure within routine evaluations of this common condition, which frequently demands intensive care and is responsible for variable neurological sequelae in economically active persons.
METHODS

Patients
The present study is part of a larger study of the use of MDCT techniques to evaluate hyperacute stroke; consequently, the protocols have been separately reviewed and approved by the Institutional Review Board and the local ethics committee.
Patients of any age or gender who presented with brain parenchyma hemorrhage ≥2.0 cm in any axis as demonstra ted by routine non-contrast CT (NCCT) from August 2011 to September 2012 were considered eligible for submission to the protocol. MDCT scanning with comparable imaging parameters, including computed tomography angiography (CTA), was performed within the first 3 days after the ictus. Informed consent was obtained from all subjects (signed personally or by their guardians).
Primary ICH was diagnosed when systemic hypertension, which was defined as blood pressure ≥140 × 90 mmHg, was the only identified etiology. We excluded patients whose ICH had occurred more than 3 days previously, those with contraindications to the intravenous iodine contrast agent, those who refused to participate in the study, and those whose examinations included images that were either of inadequate quality or contained technical artifacts.
The clinical data and laboratory results were reviewed to make a systemic arterial hypertension diagnosis. Glycemia (Gl) and blood pressure (BP) were considered according to the level. These parameters were studied separately, and their influence on both ICH expansion and inhospital mortality was analyzed. Any other etiology, solely or superimposed on systemic hypertension that could justify ICH, was considered to be additional exclusion criteria. All patients were mo nitored in the intensive care unit or emergency room and treated according to the Brazilian guidelines for the management of intracerebral hemorrhage 14 . All of the imaging examinations were conducted using a minimal dose of both ionizing radiation and intravenous iodinated contrast in a 64-slice CT scanner (Brilliance CT 64 Channel, Philips Medical, Eindhoven, The Netherlands), adding CTA to the previously requested NCCT. The CTA exa mination was performed using 120 kV and 185 milliamperes (mA), a 450mm field of view (FOV), and a pitch of 0.673. The arterial phase was performed after a time delay of 20 se conds by injecting iodine contrast at 4-6 ml/s in a dualhead po wer injector (Medrad, Warrendale, USA) with an 18G i.v. access, generally located in a peripheral vein, at a total dose of 1.5 ml/kg. The venous phase was obtained using identical parameters 60 seconds after the beginning of contrast administration. The control CT study was performed using similar parameters, but without contrast (NCCT), according to clinical judgment.
Imaging analysis
The imaging interpretations included analysis of the NCCT and CTA source images (CTA-SI), as well as maximum intensity projection (MIP) and three-dimensional (3D) postprocessed views. All data were post-processed using commercially available software on a workstation (Extended Brilliance Workspace v3.5.0.2250, Philips Medical Systems Nederland B.V., PC Best, The Netherlands).
All of the studies were evaluated in consensus by two radiologists (AJR and MRJr) experienced in the diagnosis of ICH and in the interpretation of CTA. A spot sign was consi dered to be present or absent on CTA-SI according to the following previously defined criteria proposed by Delgado Almandoz and Romero 4 : one or more focus of contrast pooling within a hemorrhage (of any size and morphology), discontinuous from normal or abnormal vasculature adjacent to the hemorrhage, and attenuation ≥120 UH.
The hematoma volumes were calculated at the first NCCT scanning and at imaging follow-up, estimating the three major axes of the hematoma and multiplying the result by 0.52. Extra-axial hemorrhage was not considered in the volume calculations.
To comparatively categorize our cohort of subjects, we considered the number of extravasation foci within the ICH as well as the largest dimension of focus and attenuation in Hounsfield Units (HU) to build a spot sign score (SSS), as previously proposed 4, 15 (Table 1) . Hematoma expansion was defined at the followup NCCT by an absolute growth greater than 6 ml or a relative growth of more than 33% from the initial NCCT 3 . A poor outcome was defined as substantial hematoma expansion at followup CT, death, or the need for surgery.
Statistical analysis
Univariate analysis using either Fisher's exact test or Stu dent's t test was used to determine the relationship between the presence of the spot sign with the expansion of ICH and hospital mortality. We also used a multivariate logistic regression model to identify the independent predictors of the expansion of the hemorrhage and hospital mortality. The results were considered to be statistically significant when p<0.05.
RESULTS
According to the inclusion criteria, 155 subjects were consecutively studied during the defined period. A total of 90 patients (90/155, 58.1%) were subsequently excluded: 25 individuals (25/155, 16.1%) were excluded due to ICH that was attributed to trauma, 46 additional subjects (46/155, 29.7%) were ultimately diagnosed with secondary ICH, 15 others (15/155, 9.7%) were excluded because peripheral venous access was not possible, two subjects (2/155, 1.3%) had been evaluated more than 72 hours after ictus, and two subjects (2/155, 1.3%) were excluded due to inappropriate technical conditions or the presence of artifacts that hampered the analysis.
We enrolled 65 subjects with primary ICH to the current study, with no statistically significant differences with respect to gender or age (p=0.111). Demographic data, BP and Gl levels, ICH volume, and the elapsed time between the stroke and the initial CTA were all measured ( Table 2 ). The spot sign on CTASI was observed in 19 subjects (19/65, 29.2%). The median intracerebral blood volume was 20.7 ml, and the average volume of blood was estimated as 49.4 ml (range 1-245 ml). The average volume was 60.3 ml in the spot signpositive group (range 2.6-245 ml) and 44.9 ml in the spot signnegative group (range 1-159 ml), with no significant difference between these groups.
According to Gl levels, patients were divided into two distinct groups (Gl≤140 mg/dl and Gl≥141 mg/dl). According to their BP levels they were also divided into two others groups (BP=140-179×90-109 mmHg and BP≥180×110 mmHg). No statistical relationship was demonstrated between any of these groups and ICH expansion or in-hospital mortality (p>0.05).
All of the spot signs (19/19, 100%) were detected during the venous phase of MDCT angiography in our series of patients ( Figure 1) . Conversely, the sign was detected in 15 subjects during the arterial phase (15/19, 79%).
The frequency, sensitivity, and specificity of the spot sign in our data were compared with previously reported results (Table 3) 4 . Brain hemorrhage was categorized according to its SSS (Table 4) . When analyzed together, the SSS groups (score 1, 2, 3, and 4) exhibited an expansion of hemorrhage in 75% (6/8) of the cases compared with 9.0% (2/23) of the cases without a spot sign, and this difference was significant (p=0.002). Taken together, the SSS groups showed a mortality rate of 73.7% (14/19) versus 43.0% (20/46) among the patients who did not present this imaging finding (p=0.029).
When categorizing patients according to the SSS, we found six patients with score 1 (6/19), 10 with score 2 (10/19), one with score 3 (1/19), and two patients with score 4 (2/19). Hemorrhage expansion was observed in 9.0% (2/23) of the patients without a spot sign, in 80% (4/5) of those with score 1, and in 67% (2/3) of those with score 2. All of the patients with scores of 3 and 4 died after the initial CT and did not undergo a CT control.
A spot sign was documented in our series of patients only on the first day, even after the first 3 hours of ictus, with an 1 hours and a median of 3 hours (range 1-24  hours) . The median overall time from the ictus to CTA scanning was 6 hours in our series, and the mean was 10.9 hours (range 1-72 hours).
Multivariate logistic regression was used to analyze certain additional features, including the ICH location and volume, the presence of a spot sign, the shape and attenuation of the hemorrhage, and the duration of ictus. The incidence of mortality was primarily influenced by the ICH volume (p=0.001) and the presence of a spot sign (p=0.02), whereas the expansion of hemorrhage was only influenced by the spot sign (p=0.001). 2  10  3  2  7  9  67  70  90  3  1  0  0  1  1  -100  100  4  2  0  0  2  2  -100  100  AUC (95% CI) 
DISCUSSION
The active extravasation of contrast within a hemorrhage has been described in catheter angiography for nearly 30 years 5 . Similar findings have also been described in magnetic resonance imaging with the use of gadolinium 17 and in CTA-SI 2, 4, 5 . Recent guidelines have confirmed that rapid neuroima ging is strongly recommended to confirm the hemorrha gic nature of the stroke, while CTA may be considered useful to evaluate for underlying secondary ICH determined by structural lesions, including vascular malformations and tumors (Class IIa; Level of evidence B) and also to help identify A B C D patients at risk for hematoma expansion (Class IIb; level of evidence B) 16 . Our results agree with previous reports confirming that the presence of spot sign on CTASI is an accurate and reliable predictor of non-traumatic hemorrhage expansion, mortality, and poorer neurological outcomes 2, 4 . The current report confirmed that contrast extravasation not only is an early event in CTA-SI analysis, as the spot sign occurred after the first 3 hours of ictus in our cohort of patients, but was also documented 24 hours after the ictus. The detection of a spot sign in our series of patients was less frequent than in certain previous reported series 2, 22, 23, 25, 27 , most likely due to their shorter delay before arriving at the hospital. Spot sign detection is higher if the CTA is obtained within the first 3 hours after stroke 2, 27 , but it has also been documented after this period and can be detected during both phases of MDCT angiography (arterial and venous) 3, 4 . The reported frequency of these delayed spot signs, which are detected during the venous phase of MDCT angiography, ranges from 8% to 23% of all the spot signs identified in various series 4 . The venous phase of CTA was also the most important for the detection of the spot sign in our series, allowing for its detection in 21% of the patients.
Appropriated institutional imaging protocols for MDCT, including CTA, must be carefully defined in order to avoid unnecessary radiation exposure and intravenous contrast administration. The use of this technique is supported by the current literature 4, [6] [7] [8] [9] . Delgado-Almandoz et al. 4 ,15 defined CTA-SI parameters appropriate for the diagnosis of the spot sign within ICH. To predict a variable risk for the various types of spot signs, these authors have proposed a score that considers the number of foci of leakage inside of the hemorrhage, and the size of greater focus and its attenuation. To the best of our knowledge, this is the first study that uses the same CTA approach to both detect and categorize spot signs in a Brazilian cohort of patients.
Our data are consistent with previously published results, confirming similar results in the detection of spot sign within ICH and reinforcing the applicability of CTA to clarify the risk of a worse prognosis, including in-hospital morta lity 3, 4, 16 . The demographic data among our patients were similar to those in previous studies 1, 4 . Despite the higher mortality among those patients with hyperglycemia, our results did not confirm statistical significance. Probably the small number of patients in the defined groups has limited the analysis. Different levels of high BP were also not correlated with the worse prognosis in this series. Conversely, international guidelines have defined that normoglycemia is recommen ded (Class I, Level of evidence C), while BP should be monitored according to previously defined parameters (Class IIb; Level of evidence C) 16 . Despite that, optimal management of high BP and hyperglycemia in ICH remains to be clarified 14, 16 . The current literature suggests applying careful interpretation to recognize results that can mimic spot sign on CTA-SI. Some of these results may be due to vascular causes, such as aneurysms and arteriovenous malformations that have continuity with adjacent vessels, facilitating recognition 18 . There are also nonvascular causes that can mimic spot signs on CTASI, such as heterogeneous bleeding and calcification foci. All of these findings should be scrutinized on both NCCT and CTA to avoid the misdiagnosis of spot signs.
Our report has certain limitations, including the delayed arrival of the patients to our center and the smaller sample of patients relative to previous series 4, 15, 23, 26 . Although the majority of our patients self-reported themselves as Caucasians, the incidence of miscegenation in our population is well known [10] [11] [12] [13] . Certain ethnic variations, including miscegenation and concurrent uncontrolled systemic arterial hypertension, may contribute to more severe ICH outcomes among Latin Americans [10] [11] [12] [13] . Further controlled studies using he mostatic drugs in Latin American subjects remain necessary to examine the expansion of hemorrhage with variable clinical outcome improvements, as previously reported among populations in developed countries [19] [20] [21] . The authors encourage the use of this standardized MDCT protocol, including both arterial and venous phases, in an imaging work-up for ICH among Brazilian patients who arrive at the hospital during the first 24 hours after ictus. An appropriate approach and specific treatment might support the adoption of public policies in treating Brazilian patients with ICH, ensuring earlier and more efficient treatment.
In conclusion, the incidence of a spot sign on CTA-SI was positively associated with hematoma expansion, a poor prognosis, and mortality in our Brazilian cohort of patients with primary ICH. Our results reinforce the hypothesis that CTA-SI is useful to detect the spot sign during the first 24 hours after primary ICH, particularly when considering venous phase CTA 3 hours after ictus. These findings also support the conclusions that a higher score (SSS) significantly increases the chance of death and that even the presence of a spot sign is an independent strong predictor of hematoma expansion.
